{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:19:35Z","timestamp":1782181175347,"version":"3.54.5"},"reference-count":38,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:p>Background: Higher late-life body mass index (BMI) was associated with reduced risk of Alzheimer\u2019s disease (AD), which might be explained by a reverse causal relationship. Objective: To investigate whether weight loss was a preclinical manifestation of AD pathologies and could be a predictor of cognitive impairment. Methods: A total of 1,194 participants (mean age\u200a=\u200a73.2 [range: 54 to 91] years, female\u200a=\u200a44.5%) from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) were grouped according to AD biomarker profile as indicated by amyloid (A) and tau (TN) status and clinical stage by clinical dementia rating (CDR). BMI across the biomarker-defined clinical stages was compared with Bonferroni correction. Pearson correlation analysis was performed to test the relationship between the amyloid change by PET and the BMI change. Multiple regression models were used to explore the influences of amyloid pathologies on BMI change as well as the effects of weight loss on longitudinal changes of global cognitive function. Results: BMI was significantly decreased in AD preclinical stage (amyloid positive [A+] and CDR\u200a=\u200a0) and dementia stage (A+\/TN+ and CDR\u200a=\u200a0.5 or 1), compared with the healthy controls (A\u2013\/TN\u2013and CDR\u200a=\u200a0, p\u200a&lt;\u200a0.005), while no significant differences were observed between preclinical AD and AD dementia. Amyloid PET change was inversely correlated with BMI change (p\u200a=\u200a0.023, \u03b2=\u200a\u201314). Individuals in amyloid positive group exhibited faster weight loss (time\u00d7group interaction p\u200a=\u200a0.019, \u03b2=\u200a\u20130.20) compared to the amyloid negative group. Greater weight loss predicted higher risk of developing cognitive disorders. Conclusion: Elders who experienced greater weight loss might belong to preclinical stage of AD and could be targeted for primary prevention of the disease.<\/jats:p>","DOI":"10.3233\/jad-200524","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:52:44Z","timestamp":1594896764000},"page":"449-456","source":"Crossref","is-referenced-by-count":15,"title":["Weight Loss is a Preclinical Signal of Cerebral Amyloid Deposition and Could Predict Cognitive Impairment in Elderly Adults"],"prefix":"10.1177","volume":"77","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Rong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200524_ref1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jalz.2017.09.016","article-title":"Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals","volume":"14","author":"Kivimaki","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref2","first-page":"1299","article-title":"Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease","volume":"86","author":"Xu","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-200524_ref3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3233\/JAD-191216","article-title":"Sex-specific association of lifetime body mass index with Alzheimer\u2019s disease neuroimaging biomarkers","volume":"75","author":"Lee","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200524_ref4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-190154","article-title":"Higher body mass index is associated with lower cortical amyloid-beta burden in cognitively normal individuals in late-life","volume":"69","author":"Thirunavu","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200524_ref5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-150987","article-title":"Lower late-life body-mass index is associated with higher cortical amyloid burden in clinically normal elderly","volume":"53","author":"Hsu","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200524_ref6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1212\/WNL.0b013e318238eec1","article-title":"Alzheimer disease biomarkers are associated with body mass index","volume":"77","author":"Vidoni","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-200524_ref7","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.neurobiolaging.2011.05.005","article-title":"Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer\u2019s disease","volume":"33","author":"Ewers","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200524_ref8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-170064","article-title":"Relationship between body mass index, ApoE4 status, and PET-based amyloid and neurodegeneration markers in amyloid-positive subjects with normal cognition or mild cognitive impairment","volume":"65","author":"Blautzik","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200524_ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12603-018-1121-6","article-title":"Is fat mass cross-sectionally associated with cortical Abeta load in the human brain?","volume":"23","author":"Maltais","year":"2019","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-200524_ref10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-200524_ref11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jalz.2010.03.007","article-title":"The Alzheimer\u2019s disease neuroimaging initiative: Progress report and future plans","volume":"6","author":"Weiner","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jalz.2012.04.007","article-title":"Worldwide Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"8","author":"Carrillo","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-200524_ref15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neurobiolaging.2010.05.003","article-title":"3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects","volume":"31","author":"Apostolova","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200524_ref16","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-200524_ref17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-200524_ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-beta pathology","volume":"14","author":"Suarez-Calvet","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-200524_ref19","doi-asserted-by":"crossref","first-page":"e9712","DOI":"10.15252\/emmm.201809712","article-title":"CSF progranulin increases in the course of Alzheimer\u2019s disease and is associated with sTREM2, neurodegeneration and cognitive decline","volume":"10","author":"Suarez-Calvet","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-200524_ref20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-200524_ref22","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exger.2017.10.013","article-title":"Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer\u2019s pathology in MCI and mild dementia","volume":"100","author":"Mathys","year":"2017","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-200524_ref24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-150556","article-title":"Unstable body mass index and progression to probable Alzheimer\u2019s disease dementia in patients with amnestic mild cognitive impairment","volume":"49","author":"Ye","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200524_ref25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/dc18-1667","article-title":"BMI, weight change, and dementia risk in patients with new-onset type 2 diabetes: A nationwide cohort study","volume":"42","author":"Nam","year":"2019","journal-title":"Diabetes Care"},{"key":"10.3233\/JAD-200524_ref26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","article-title":"Change in body mass index and risk of incident Alzheimer disease","volume":"65","author":"Buchman","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-200524_ref27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1567205010666131120110930","article-title":"Change in body mass index before and after Alzheimer\u2019s disease onset","volume":"11","author":"Gu","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-200524_ref28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41598-017-01327-w","article-title":"Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer\u2019s disease","volume":"7","author":"Muller","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-200524_ref29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archneur.62.1.55","article-title":"A 32-year prospective study of change in body weight and incident dementia: The Honolulu-Asia Aging Study","volume":"62","author":"Stewart","year":"2005","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-200524_ref30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-161205","article-title":"Modeling the relationships among late-life body mass index, cerebrovascular disease, and Alzheimer\u2019s disease neuropathology in an autopsy sample of 1,421 subjects from the National Alzheimer\u2019s Coordinating Center Data Set","volume":"57","author":"Alosco","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200524_ref31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.63.9.1312","article-title":"Accelerated weight loss may precede diagnosis in Alzheimer disease","volume":"63","author":"Johnson","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-200524_ref32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jalz.2015.05.015","article-title":"Genetically predicted body mass index and Alzheimer\u2019s disease-related phenotypes in three large samples: Mendelian randomization analyses","volume":"11","author":"Mukherjee","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200524_ref33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2020.03.002","article-title":"Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults","volume":"93","author":"Rabin","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200524_ref34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2016.11.017","article-title":"Weight loss is associated with improvements in cognitive function among overweight and obese people: A systematic review and meta-analysis","volume":"72","author":"Veronese","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-200524_ref35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41598-017-18388-6","article-title":"Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice","volume":"8","author":"Meakin","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-200524_ref36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1471-4159.2010.06929.x","article-title":"beta-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway","volume":"115","author":"Marwarha","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-200524_ref37","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1152\/ajpendo.00279.2018","article-title":"Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues","volume":"316","author":"Kulas","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3233\/JAD-200524_ref38","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bbadis.2015.10.029","article-title":"Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology","volume":"1862","author":"Ishii","year":"2016","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:37Z","timestamp":1777370917000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":38,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-200524","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}